Details for New Drug Application (NDA): 209517
✉ Email this page to a colleague
The generic ingredient in LACTULOSE is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
Summary for 209517
Tradename: | LACTULOSE |
Applicant: | Chartwell Rx |
Ingredient: | lactulose |
Patents: | 0 |
Pharmacology for NDA: 209517
Mechanism of Action | Acidifying Activity Osmotic Activity |
Physiological Effect | Stimulation Large Intestine Fluid/Electrolyte Secretion |
Medical Subject Heading (MeSH) Categories for 209517
Suppliers and Packaging for NDA: 209517
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LACTULOSE | lactulose | SOLUTION;ORAL | 209517 | ANDA | Chartwell RX, LLC | 62135-002 | 62135-002-24 | 2 TRAY in 1 BOX (62135-002-24) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (62135-002-51) |
LACTULOSE | lactulose | SOLUTION;ORAL | 209517 | ANDA | Chartwell RX, LLC | 62135-002 | 62135-002-37 | 237 mL in 1 PACKAGE (62135-002-37) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 10GM/15ML | ||||
Approval Date: | Nov 23, 2018 | TE: | AA | RLD: | No |
Complete Access Available with Subscription